RE:RE:RE:RE:Cool...we get to sell a whooping 1000kgs SandstoneMiner wrote: Dont forget Netherlands, one of those articles mentioned over half of german pharmaceutical sales came from Netherlands and the rest from Canada. Not APHA though as apparently they are not EU certified yet.
Medicalweedz wrote: That's German grow. What that doesn't cover the rest will be exported from Canada
Yukon you fail to see the business model. Every country will stop importing MJ if they can and have it home grow. The individual countries will have better control of the quality, pricing, more so they generate tax dollars for themselves. Not to mention MJ creates many jobs for the local economy. Importing will be a for the most part non existent. Germany will one day stop importing . They have no reason to continue once the cultivation licences are in place and they can gro enough to meet their demand. APHA, ACB and WAYL have the first mover advantage. APHA is far ahaed because they have CC pharma to package and distribute the product and they will have a few pain centres set up through Schoneberg hospital. Do you get the model now? APHA grows the product . CC pharma packages/ lables the product . The doctors at Schoneberg and other pain centers which they will set up prescribe the product. CC Pharma ships it out product to the pharmacies. The prescriptions are then filled. I see it as pure top to bottom channel. It does not get better.